KRAS and acute lymphoblastic leukemia: As well, it is notable that mouse T-ALL with activated Kras(G12D) show greater sensitivity to MEK inhibition as compared to Kras(WT) tumors, suggesting that activated Ras induces so-called “oncogene addiction”, but is otherwise not generally advantageous in T-ALL.